V
Vincent Maher
Researcher at Tallaght Hospital
Publications - 65
Citations - 6491
Vincent Maher is an academic researcher from Tallaght Hospital. The author has contributed to research in topics: Cholesterol & Lipoprotein. The author has an hindex of 21, co-authored 65 publications receiving 3755 citations. Previous affiliations of Vincent Maher include Institute of Technology, Tallaght & BlackRock.
Papers
More filters
Journal ArticleDOI
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
François Mach,Colin Baigent,Alberico L. Catapano,Konstantinos C. Koskinas,Manuela Casula,Lina Badimon,M. John Chapman,Guy De Backer,Victoria Delgado,Brian A. Ference,Ian D. Graham,Alison Halliday,Ulf Landmesser,Borislava Mihaylova,Terje R. Pedersen,Gabriele Riccardi,Dimitrios J. Richter,Marc S. Sabatine,Marja-Riitta Taskinen,Lale Tokgozoglu,Olov Wiklund,Christian Mueller,Heinz Drexel,Victor Aboyans,Alberto Corsini,Wolfram Doehner,Michel Farnier,Bruna Gigante,Meral Kayıkçıoğlu,Goran Krstacic,Ekaterini Lambrinou,Basil S. Lewis,Josep Masip,Philippe Moulin,Steffen E. Petersen,Anna Sonia Petronio,Massimo F Piepoli,Xavier Pintó,Lorenz Räber,Kausik K. Ray,Željko Reiner,Walter F Riesen,Marco Roffi,Jean-Paul Schmid,Evgeny Shlyakhto,Iain A. Simpson,Erik S.G. Stroes,Isabella Sudano,Alexandros D Tselepis,Margus Viigimaa,Cecile Vindis,Alexander Vonbank,Michal Vrablik,Mislav Vrsalovic,José Luis Zamorano,Jean-Philippe Collet,Stephan Windecker,Veronica Dean,Donna Fitzsimons,Chris P Gale,Diederick E. Grobbee,Sigrun Halvorsen,Gerhard Hindricks,Bernard Iung,Peter Jüni,Hugo A. Katus,Christophe Leclercq,Maddalena Lettino,Béla Merkely,Miguel Sousa-Uva,Rhian M. Touyz,Djamaleddine Nibouche,Parounak H. Zelveian,Peter Siostrzonek,Ruslan Najafov,Philippe van de Borne,Belma Pojskic,Arman Postadzhiyan,Lambros Kypris,Jindřich Špinar,Mogens Lytken Larsen,Hesham Salah Eldin,Timo E. Strandberg,Jean Ferrières,Rusudan Agladze,Ulrich Laufs,Loukianos S. Rallidis,Laszlo Bajnok,Thorbjorn Gudjonsson,Vincent Maher,Yaakov Henkin,Michele Massimo Gulizia,Aisulu Mussagaliyeva,Gani Bajraktari,Alina Kerimkulova,Gustavs Latkovskis,Omar Hamoui,Rimvydas Šlapikas,Laurent Visser,P. Dingli,Victoria Ivanov,Aneta Boskovic,Mbarek Nazzi,Frank L.J. Visseren,Irena Mitevska,Kjetil Retterstøl,Piotr Jankowski,Ricardo Fontes-Carvalho,Dan Gaita,Marat V. Ezhov,Marina Foscoli,Vojislav Giga,Daniel Pella,Zlatko Fras,Leopoldo Pérez de Isla,Emil Hagström,Roger Lehmann,Leila Abid,Oner Ozdogan,Olena Mitchenko,Riyaz S. Patel +120 more
Journal ArticleDOI
Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a).
TL;DR: In men with CAD and elevated LDL-C, Lp(a) levels were dominant correlates of baseline disease severity, its progression, and event rate over 2.5 years.
Journal ArticleDOI
EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study
Kausik K. Ray,Bart Molemans,W. Marieke Schoonen,Periklis Giovas,Sarah Bray,Gaia Kiru,Jennifer Murphy,Maciej Banach,Maciej Banach,Maciej Banach,Stefano De Servi,Dan Gaita,Ioanna Gouni-Berthold,G. Kees Hovingh,Jacek Jerzy Jozwiak,J. Wouter Jukema,Róbert Gábor Kiss,Serge Kownator,Helle K. Iversen,Vincent Maher,Luis Masana,Alexander Parkhomenko,André Peeters,Piers Clifford,Katarina Raslova,Peter Siostrzonek,Stefano Romeo,Stefano Romeo,Stefano Romeo,Dimitrios Tousoulis,Charalambos Vlachopoulos,Michal Vrablík,Alberico L. Catapano,Neil R Poulter,DA Vinci study +34 more
TL;DR: In this article, the authors provide contemporary data on the implementation of European guideline recommendations for lipid-lowering therapies (LLTs) across different settings and populations and how this impacts low-density lipoprotein cholesterol (LDL-C) goal achievement.
Journal ArticleDOI
Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis
Gilbert R. Thompson,Vincent Maher,Yuri Kitano,Clare Neuwirth,Graham J. Davies,Stephanie Beatrix Matthews,M.B. Shortt,A. Rees,A. Mir,A. Henderson,Robin J Prescott,P. de Feyter +11 more
TL;DR: Although LDL apheresis combined with simVastatin was more effective than colestipol plus simvastatin in reducing LDL cholesterol and lipoprotein(a), it was less beneficial in influencing coronary atherosclerosis and should be reserved for patients unresponsive to drugs.
Journal ArticleDOI
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).
Antonio J. Vallejo-Vaz,Martina De Marco,C. Stevens,Asif Akram,Tomáš Freiberger,G. Kees Hovingh,John J.P. Kastelein,Pedro Mata,Frederick J. Raal,Raul D. Santos,Handrean Soran,Gerald F. Watts,Marianne Abifadel,Carlos A. Aguilar-Salinas,Mutaz Alkhnifsawi,Fahad Alkindi,Fahad Alnouri,Rodrigo Alonso,Khalid Al-Rasadi,Ahmad Al-Sarraf,T.F. Ashavaid,Christoph J. Binder,Martin Prøven Bogsrud,Mafalda Bourbon,Eric Bruckert,Krzysztof Chlebus,Pablo Corral,Olivier S. Descamps,Ronen Durst,Marat V. Ezhov,Zlatko Fras,Jacques Genest,Urh Groselj,Mariko Harada-Shiba,Meral Kayıkçıoğlu,Katarina Lalic,Carolyn S.P. Lam,Gustavs Latkovskis,Ulrich Laufs,Evangelos Liberopoulos,Jie Lin,Vincent Maher,Nelson Majano,A. David Marais,Winfried März,Erkin M. Mirrakhimov,André R. Miserez,Olena Mitchenko,Hapizah Nawawi,Børge G. Nordestgaard,György Paragh,Zaneta Petrulioniene,Belma Pojskic,Arman Postadzhiyan,Ashraf Reda,Željko Reiner,Wilson E Sadoh,Amirhossein Sahebkar,Abdullah Shehab,Aleksander B Shek,Mario Stoll,Ta-Chen Su,Tavintharan Subramaniam,Andrey V. Susekov,Phivos Symeonides,Myra Tilney,Brian Tomlinson,Thanh-Huong Truong,Alexandros D. Tselepis,Anne Tybjærg-Hansen,Alejandra Vázquez-Cárdenas,Margus Viigimaa,Branislav Vohnout,Elisabeth Widen,Shizuya Yamashita,Maciej Banach,Dan Gaita,Lixin Jiang,Lennart Nilsson,Lourdes Ella G. Santos,Heribert Schunkert,Lale Tokgozoglu,Josip Car,Alberico L. Catapano,Kausik K. Ray +84 more
TL;DR: FH is a recognised public health concern, with overall suboptimal identification and under-treatment, and efforts and initiatives to improve FH knowledge and management are underway, but support from health authorities and better funding are greatly needed.